Acquisition method of high-concentration uterine blood stem cell exosome and application of high-concentration uterine blood stem cell exosome in infertility diagnosis

Through the method of collecting and purifying exosomes of uterine blood stem cell, the problems of low exosome production efficiency and inconsistent composition in the prior art are solved, and high concentration and high purity exosome acquisition is achieved for infertility diagnosis miRNA detection in.

CN118909933APending Publication Date: 2024-11-08NANTONG XINGZHONG CELL ENG CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410868199.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-01
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The prior art is inefficient in large-scale production of uterine blood stem cell exosomes, and high-glycemic culture media leads to cell aging and inconsistent components, making it difficult to obtain high concentration and high purity exosomes.

Method used

By collecting uterine blood stem cells, PBS mixing, lymphatic separator centrifugation, HBSS culture, MSC NutriStem® XF medium amplification, cell culture medium supernatant extraction, ultracentrifugation and exclusion chromatography purification, obtaining high concentration Uterine blood stem cell exosomes.

Benefits of technology

Acquisition of high concentration and high purity uterine blood stem cell exosomes, used for the detection of overexpression markers of miRNA-92a and miRNA-130b in infertility diagnosis, improving productivity and balancing high-sugar culture medium use.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention discloses a method for obtaining a high-concentration uterine blood stem cell exosome and application of the high-concentration uterine blood stem cell exosome in infertility diagnosis, and the diagnosis of infertility is realized through overexpression or high expression of miRNA-92a and miRNA-130b in the obtained high-concentration uterine blood stem cell exosome.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biotechnology, and in particular to a method for obtaining high-concentration uterine blood stem cell exosomes and an application thereof in infertility diagnosis. Background Art

[0002] Exosomes are a type of bilayer lipid vesicles with a diameter of 30-100nm that can be produced by different cells, and contain substances such as proteins and RNA. Menstrual blood derived mesenchymal stem cells (MenSCs) are a new source of adult mesenchymal stem cells, which are derived from women's menstrual blood and have the advantages of being easy to obtain, safe and free of ethical issues. The therapeutic effect of mesenchymal stem cells depends largely on the cytokines contained in the exosomes from which they are derived, because the production of naturally secreted exosomes is far from meeting the application needs.

[0003] At present, the main ways to mass produce exosomes are: using dozens of large (such as T-225) cell culture bottles, multiple multi-layer stacked array cell culture bottles, large fixed bed bioreactors, and using microcarriers or continuous production perfusion reactors for cell expansion. The composition and activity of exosomes reflect the physiological state of cells when they are secreted and have nothing to do with physiological or in vivo conditions. However, the current large-scale production has common limitations, especially low efficiency. In addition, during production, the serum contains a large amount of contaminated endogenous exosomes, and serum-free culture medium is required for cell expansion. At the same time, due to the cost of expanding production, high-glucose culture medium has become the first choice for mesenchymal stem cell expansion, but high-glucose culture medium will accelerate cell aging, making the exosome composition inconsistent during long-term cell culture. Therefore, how to improve the production efficiency of exosomes and balance the serum contradiction of high-glucose culture medium is the current research direction. Summary of the invention

[0004] The technical problem to be solved by the present invention is to provide a method for obtaining high-concentration uterine blood stem cell exosomes to obtain high-concentration and high-purity uterine blood stem cell exosomes.

[0005] In order to solve the above technical problems, the present invention adopts the following technical solution: a method for obtaining high-concentration uterine blood stem cell exosomes, characterized in that it comprises the following steps: (1) Filtering and centrifuging the collected menstrual blood to collect uterine blood stem cells; (2) Add an appropriate amount of PBS to the collected uterine blood stem cells, mix well, shake and filter, then add lymph separation fluid, and then centrifuge and stratify the liquid; (3) Collecting uterine blood stem cells from the stratification fluid; (4) After the collected uterine blood stem cells are placed in HBSS for culture, they are centrifuged and filtered to collect the uterine blood stem cells; (5) In a 5% CO2 atmosphere at 38°C, uterine blood stem cells were expanded using MSC NutriStem® XF medium, and the cell culture supernatant was collected after expansion; (6) Extracting exosomes from uterine blood stem cells using the supernatant of cell culture fluid; (7) Purifying uterine blood stem cell exosomes to obtain high-concentration uterine blood stem cell exosomes.

[0006] Furthermore, in step (1), the ratio of uterine blood stem cells to PBS is 1:2.2.

[0007] Furthermore, in step (5), the uterine blood stem cells were inoculated in MSCNutriStem® XF culture medium at a seeding amount of 1×108 cells / mL for cell expansion.

[0008] Furthermore, on the 5th day, the cells were washed twice with PBS and replaced with new MSC NutriStem® XF medium. When the cells reached 78% confluence, the cells were washed twice with PBS and replaced with DMEM medium. Amino acid mixture, glucose solution, vitamin solution and 10% fetal bovine serum were added to the DMEM medium. When the cells reached 80% confluence, the cell culture supernatant was collected.

[0009] Furthermore, in step (6), the cell culture supernatant is subjected to three ultracentrifugations to obtain uterine blood stem cell exosomes.

[0010] Furthermore, in step (7), ultracentrifugation purification and size exclusion chromatography purification are performed sequentially.

[0011] The present invention provides an application of high-concentration uterine blood stem cell exosomes obtained in infertility diagnosis, wherein miRNA-92a and miRNA-130b are overexpressed or highly expressed.

[0012] The beneficial effects of the present invention are: (1) Uterine blood stem cells are mesenchymal stem cells with multidirectional differentiation functions, characterized by abundant sources, weak immunogenicity and strong proliferation ability.

[0013] (2) Exosomes participate in gamete development and embryo formation by transferring their contents, miRNA, between cells. Exosomes can be used as markers to diagnose infertility. DETAILED DESCRIPTION

[0014] The technical solution of the present invention will be clearly and completely described below through specific implementation methods.

[0015] A method for obtaining high-concentration uterine blood stem cell exosomes of the present invention comprises the following steps: (1) Filtering and centrifuging the collected menstrual blood to collect uterine blood stem cells; (2) Add an appropriate amount of PBS to the collected uterine blood stem cells, mix well, shake and filter, then add lymph separation fluid, and then centrifuge and stratify the liquid; (3) Collecting uterine blood stem cells from the stratification fluid; (4) After the collected uterine blood stem cells are placed in HBSS for culture, they are centrifuged and filtered to collect the uterine blood stem cells; (5) In a 5% CO2 atmosphere at 38°C, uterine blood stem cells were expanded using MSC NutriStem® XF medium, and the cell culture supernatant was collected after expansion; (6) Extracting exosomes from uterine blood stem cells using the supernatant of cell culture fluid; (7) Purifying uterine blood stem cell exosomes to obtain high-concentration uterine blood stem cell exosomes.

[0016] In step (1), the ratio of uterine blood stem cells to PBS is 1:2.2.

[0017] In step (5), uterine blood stem cells were inoculated in MSC NutriStem® XF medium at a seeding volume of 1×108 cells / mL for cell expansion.

[0018] On the 5th day, the cells were washed twice with PBS and replaced with new MSC NutriStem® XF medium. When the cells reached 78% confluence, the cells were washed twice with PBS and replaced with DMEM medium. Amino acid mixture, glucose solution, vitamin solution and 10% fetal bovine serum were added to the DMEM medium. When the cells reached 80% confluence, the cell culture supernatant was collected.

[0019] In step (6), the cell culture supernatant is subjected to three ultracentrifugations to obtain uterine blood stem cell exosomes.

[0020] In step (7), ultracentrifugation purification and size exclusion chromatography purification are performed sequentially.

[0021] MiRNA in exosomes is a type of endogenous, hairpin-structured small RNA with a length of about 20-24 nucleotides, which is generated by single-stranded RNA precursors processed by Dicer enzymes. MiRNA has an important function of regulating gene expression in the body.

[0022] A clinical study collected exosomes of uterine blood stem cells from 200 women, 100 of whom were women with normal constitutions and the other 100 were infertile patients. Their miRNAs were studied, and the results showed that all 100 infertile patients had overexpression or high expression of miRNA-92a and miRNA-130b, while only 2 of the other 100 normal women had overexpression or high expression of miRNA-92a and miRNA-130b.

[0023] Therefore, high concentration of uterine blood stem cell exosomes are used in the diagnosis of infertility to assist in diagnosis.

[0024] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Those skilled in the art may make various modifications or equivalent substitutions to the present invention within the essence and protection scope of the present invention, and such modifications or equivalent substitutions should also be deemed to fall within the protection scope of the technical solution of the present invention.

Claims

1. A method for obtaining high-concentration uterine blood stem cell exosomes, Features: The following steps are involved: (1) Filtering and centrifuging the collected menstrual blood to collect uterine blood stem cells; (2) Add an appropriate amount of PBS to the collected uterine blood stem cells, mix well, shake and filter, then add lymph separation fluid, and then centrifuge and stratify the liquid; (3) Collecting uterine blood stem cells from the stratification fluid; (4) After the collected uterine blood stem cells are placed in HBSS for culture, they are centrifuged and filtered to collect the uterine blood stem cells; (5) In a 5% CO2 atmosphere at 38°C, uterine blood stem cells were expanded using MSC NutriStem® XF medium, and the cell culture supernatant was collected after expansion; (6) Extracting exosomes from uterine blood stem cells using the supernatant of cell culture fluid; (7) Purifying uterine blood stem cell exosomes to obtain high-concentration uterine blood stem cell exosomes.

2. A method for obtaining high-concentration uterine blood stem cell exosomes according to claim 1, Features: In step (1), the ratio of uterine blood stem cells to PBS is 1:2.

2.

3. A method for obtaining high-concentration uterine blood stem cell exosomes according to claim 1, Features: In step (5), uterine blood stem cells were inoculated in MSC NutriStem® XF medium at a seeding volume of 1×108 cells / mL for cell expansion.

4. A method for obtaining high-concentration uterine blood stem cell exosomes according to claim 1, Features: On the 5th day, the cells were washed twice with PBS and replaced with new MSC NutriStem® XF medium. When the cells reached 78% confluence, the cells were washed twice with PBS and replaced with DMEM medium. Amino acid mixture, glucose solution, vitamin solution and 10% fetal bovine serum were added to the DMEM medium. When the cells reached 80% confluence, the cell culture supernatant was collected.

5. The method for obtaining high-concentration uterine blood stem cell exosomes according to claim 1, Features: In step (6), the cell culture supernatant is subjected to three ultracentrifugations to obtain uterine blood stem cell exosomes.

6. The method for obtaining high-concentration uterine blood stem cell exosomes according to claim 1, Features: In step (7), ultracentrifugation purification and size exclusion chromatography purification are performed sequentially.

7. Use of high-concentration uterine blood stem cell exosomes obtained according to any one of claims 1 to 6 in the diagnosis of infertility, wherein miRNA-92a and miRNA-130b are overexpressed or highly expressed.